James M. Reuben

2.8k total citations
47 papers, 2.2k citations indexed

About

James M. Reuben is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, James M. Reuben has authored 47 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 15 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in James M. Reuben's work include Toxin Mechanisms and Immunotoxins (7 papers), HIV Research and Treatment (6 papers) and Immune Cell Function and Interaction (6 papers). James M. Reuben is often cited by papers focused on Toxin Mechanisms and Immunotoxins (7 papers), HIV Research and Treatment (6 papers) and Immune Cell Function and Interaction (6 papers). James M. Reuben collaborates with scholars based in United States, United Kingdom and Spain. James M. Reuben's co-authors include Naoto T. Ueno, Bang‐Ning Lee, CF LeMaistre, Thasia Woodworth, Xin Shelley Wang, Adrian J. Dunn, Robert Dantzer, Andrew H. Miller, Christina A. Meyers and Charles S. Cleeland and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

James M. Reuben

46 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M. Reuben United States 22 665 616 585 281 236 47 2.2k
Thomas M. Zollner Germany 32 1.3k 2.0× 862 1.4× 691 1.2× 201 0.7× 200 0.8× 105 3.6k
Katarzyna Bogunia‐Kubik Poland 28 963 1.4× 743 1.2× 408 0.7× 254 0.9× 175 0.7× 145 2.8k
Annalisa Chiocchetti Italy 33 936 1.4× 1.0k 1.6× 343 0.6× 127 0.5× 137 0.6× 101 2.9k
Tatsuhiko Miyazaki Japan 26 499 0.8× 752 1.2× 633 1.1× 457 1.6× 64 0.3× 196 2.7k
Per Sonne Holm Germany 30 177 0.3× 1.0k 1.7× 626 1.1× 161 0.6× 85 0.4× 92 2.3k
Chrong‐Reen Wang Taiwan 31 1.4k 2.1× 824 1.3× 419 0.7× 210 0.7× 171 0.7× 128 3.4k
Zhaoyang Li United States 20 530 0.8× 578 0.9× 624 1.1× 83 0.3× 180 0.8× 77 1.8k
Jeffrey D. Peterson United States 28 793 1.2× 628 1.0× 215 0.4× 168 0.6× 211 0.9× 60 2.5k
Klaus Diedrich Germany 37 613 0.9× 667 1.1× 220 0.4× 235 0.8× 113 0.5× 208 4.5k
Jennifer J. Brady Ireland 30 465 0.7× 1.7k 2.7× 594 1.0× 243 0.9× 111 0.5× 62 3.3k

Countries citing papers authored by James M. Reuben

Since Specialization
Citations

This map shows the geographic impact of James M. Reuben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Reuben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Reuben more than expected).

Fields of papers citing papers by James M. Reuben

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Reuben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Reuben. The network helps show where James M. Reuben may publish in the future.

Co-authorship network of co-authors of James M. Reuben

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Reuben. A scholar is included among the top collaborators of James M. Reuben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Reuben. James M. Reuben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jangsoon, Kumiko Kida, Jiwon Koh, et al.. (2024). The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 236–236. 9 indexed citations
2.
3.
Rahal, Omar, Adam R. Wolfe, Pijus K. Mandal, et al.. (2017). Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 100(4). 1034–1043. 128 indexed citations
4.
Illera, Juan Carlos, Sara Cáceres, L. Peña, et al.. (2015). Steroid hormone secretion in inflammatory breast cancer cell lines. Hormone Molecular Biology and Clinical Investigation. 24(3). 137–145. 12 indexed citations
5.
Mego, Michal, Zhuang Zuo, Hui Gao, et al.. (2014). Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thrombosis and Haemostasis. 113(3). 593–598. 33 indexed citations
6.
Wang, Xiaoping, Hitomi Saso, Takayuki Iwamoto, et al.. (2013). TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase. Cancer Research. 73(21). 6516–6525. 65 indexed citations
7.
Debeb, Bisrat G., Lara Lacerda, Richard Larson, et al.. (2013). Abstract 3051: The miR-200 family as a potential therapeutic target in inflammatory breast cancer.. Cancer Research. 73(8_Supplement). 3051–3051. 1 indexed citations
8.
Lu, Charles, David J. Stewart, J. Jack Lee, et al.. (2012). Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans. PLoS ONE. 7(4). e34833–e34833. 144 indexed citations
9.
Song, Yujun, Yuanqing Zhang, Paul E. Bernard, et al.. (2012). Multiplexed volumetric bar-chart chip for point-of-care diagnostics. Nature Communications. 3(1). 1283–1283. 198 indexed citations
10.
Debeb, Bisrat G., Lara Lacerda, Wei Xu, et al.. (2012). Histone Deacetylase Inhibitors Stimulate Dedifferentiation of Human Breast Cancer Cells Through WNT/β‐Catenin Signaling. Stem Cells. 30(11). 2366–2377. 98 indexed citations
11.
Gao, Hong‐Wei, Moshe Talpaz, Nicholas J. Donato, et al.. (2005). BMS-354825 induced complete hematologic remission in chronic phase CML patients without affecting T-cell cytokine production. Journal of Clinical Oncology. 23(16_suppl). 6619–6619. 3 indexed citations
12.
Gao, Hui, Moshe Talpaz, Nicholas J. Donato, et al.. (2005). Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemia. Leukemia. 19(11). 1905–1911. 41 indexed citations
13.
Cleeland, Charles S., Gary J. Bennett, Robert Dantzer, et al.. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism?. Cancer. 97(11). 2919–2925. 394 indexed citations
14.
Lee, Bang‐Ning, Hunter Hammill, Edwina J. Popek, et al.. (2001). Production of Interferons and ß‐Chemokines by Placental Trophoblasts of HIV‐1‐Infected Women. Infectious Diseases in Obstetrics and Gynecology. 9(2). 95–104. 21 indexed citations
15.
Saleh, Mansoor N., CF LeMaistre, Timothy M. Kuzel, et al.. (1998). Antitumor activity of DAB389 IL-2 fusion toxin in mycosis fungoides. Journal of the American Academy of Dermatology. 39(1). 63–73. 99 indexed citations
16.
LeMaistre, CF, C Meneghetti, Michael G. Rosenblum, et al.. (1992). Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood. 79(10). 2547–2554. 104 indexed citations
17.
Reuben, James M., et al.. (1986). RELATIONSHIP OF EXPOSURE TO HUMAN T LYMPHOTROPIC VIRUS AND T HELPER CELLS IN HOMOSEXUAL MEN. PubMed. 2(2). 117–126. 3 indexed citations
18.
19.
Reuben, James M., et al.. (1985). In vitro modulation of purine enzyme metabolism and lymphocyte surface marker expression by thymosin fraction 5 in homosexual males. International Journal of Immunopharmacology. 7(5). 661–669. 5 indexed citations
20.
Reuben, James M., et al.. (1983). IL-2 PRODUCTION AND RESPONSE IN VITRO BY THE LEUKOCYTES OF PATIENTS WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME*. PubMed. 1(5). 359–377. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas M. Zollner Breakdown of academic impact, for papers by Katarzyna Bogunia‐Kubik Breakdown of academic impact, for papers by Annalisa Chiocchetti Breakdown of academic impact, for papers by Tatsuhiko Miyazaki Breakdown of academic impact, for papers by Per Sonne Holm Breakdown of academic impact, for papers by Chrong‐Reen Wang Breakdown of academic impact, for papers by Zhaoyang Li Breakdown of academic impact, for papers by Jeffrey D. Peterson Breakdown of academic impact, for papers by Klaus Diedrich Breakdown of academic impact, for papers by Jennifer J. Brady
Rankless by CCL
2026